AP Biosciences (ROCO:6945) NonCurrent Deferred Liabilities: NT$0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6945 AP Biosciences Inc ROCO:6945
12 GF Score
Price NT$87.20
! 1 Warning Sign
View Full Analysis

What is AP Biosciences NonCurrent Deferred Liabilities?

AP Biosciences ROCO:6945 +0.23% 12 NonCurrent Deferred Liabilities is NT$0.00 Mil as of Dec. 2025. GuruFocus rates ROCO:6945 with a GF Score™ of 12/100. The stock has 1 warning sign investors should review.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

AP Biosciences's non-current deferred liabilities for the quarter that ended in Dec. 2025 was NT$0.00 Mil.

AP Biosciences NonCurrent Deferred Liabilities Related Terms

AP Biosciences NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for AP Biosciences's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AP Biosciences NonCurrent Deferred Liabilities Chart

AP Biosciences Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

AP Biosciences Quarterly Data
Dec20 Dec21 Dec22 Jun23 Dec23 Jun24 Sep24 Dec24 Jun25 Sep25 Dec25
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ROCO:6945
12GF Score
AP Biosciences Inc ROCO:6945
NonCurrent Deferred Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Liabilities of NT$0.00 Mil mean?
AP Biosciences (ROCO:6945) has a NonCurrent Deferred Liabilities of NT$0.00 Mil as of Dec. 2025. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on AP Biosciences and its competitors.
Is AP Biosciences' NonCurrent Deferred Liabilities too high?
AP Biosciences' current NonCurrent Deferred Liabilities is NT$0.00 Mil. Overall, AP Biosciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does AP Biosciences' NonCurrent Deferred Liabilities compare to VRTX and REGN?
AP Biosciences' NonCurrent Deferred Liabilities of NT$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Biotechnology company?
A good NonCurrent Deferred Liabilities depends on the Biotechnology industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on AP Biosciences and its competitors. AP Biosciences's current NonCurrent Deferred Liabilities is NT$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AP Biosciences stock overvalued right now?
AP Biosciences (ROCO:6945) has a current NonCurrent Deferred Liabilities of NT$0.00 Mil. The current NonCurrent Deferred Liabilities is NT$0.00 Mil. AP Biosciences' overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For AP Biosciences (ROCO:6945), the current NonCurrent Deferred Liabilities is NT$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AP Biosciences Business Description

Address No. 3, Park Street, 17th Floor, Taipei, TWN
AP Biosciences Inc is a clinical-stage bispecific antibody new drug research and development company. It has developed a series of antibody and protein lead drugs through a self-designed technology platform for unmet medical needs, focusing on Specific targets associated with diseases to deliver safe, effective and cost-effective medicines.
12GF Score

Get the complete analysis for ROCO:6945

NonCurrent Deferred Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$87.20
Price